Literature DB >> 3145405

Platelet-derived growth factor does not induce c-fos in NIH 3T3 cells expressing the EJ-ras oncogene.

A H Lin1, V E Groppi, R R Gorman.   

Abstract

Platelet-derived growth factor (PDGF), the calcium ionophore A23187, and the tumor promoter phorbol myristate acetate stimulated c-fos mRNA levels in control NIH 3T3 cells. However, NIH 3T3 cells transformed by EJ-ras DNA transfection, which have diminished PDGF-stimulated phospholipase C activity, showed a 95% reduction in PDGF-stimulated c-fos mRNA levels. The responses to A23187 and phorbol myristate acetate were also attenuated, but not as severely as the PDGF-mediated induction. The reduction in PDGF-stimulated c-fos induction did not appear to be a general result of cellular transformation, since src-transformed NIH 3T3 cells displayed a strong PDGF-stimulated c-fos induction. Despite the reduction in PDGF-stimulated c-fos induction, EJ-ras-transformed cells still responded mitogenically to PDGF. These data suggest that the magnitude of c-fos induction cannot be directly correlated with PDGF-stimulated mitogenesis in EJ-ras-transformed NIH 3T3 cells.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3145405      PMCID: PMC365601          DOI: 10.1128/mcb.8.11.5052-5055.1988

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  40 in total

1.  Ribonucleic acid isolated by cesium chloride centrifugation.

Authors:  V Glisin; R Crkvenjakov; C Byus
Journal:  Biochemistry       Date:  1974-06-04       Impact factor: 3.162

2.  The p21 src genes of Harvey and Kirsten sarcoma viruses originate from divergent members of a family of normal vertebrate genes.

Authors:  R W Ellis; D Defeo; T Y Shih; M A Gonda; H A Young; N Tsuchida; D R Lowy; E M Scolnick
Journal:  Nature       Date:  1981-08-06       Impact factor: 49.962

3.  Structure and variation of human ribosomal DNA: molecular analysis of cloned fragments.

Authors:  J M Erickson; C L Rushford; D J Dorney; G N Wilson; R D Schmickel
Journal:  Gene       Date:  1981-12       Impact factor: 3.688

4.  T24 human bladder carcinoma oncogene is an activated form of the normal human homologue of BALB- and Harvey-MSV transforming genes.

Authors:  E Santos; S R Tronick; S A Aaronson; S Pulciani; M Barbacid
Journal:  Nature       Date:  1982-07-22       Impact factor: 49.962

5.  Transforming genes of human bladder and lung carcinoma cell lines are homologous to the ras genes of Harvey and Kirsten sarcoma viruses.

Authors:  C J Der; T G Krontiris; G M Cooper
Journal:  Proc Natl Acad Sci U S A       Date:  1982-06       Impact factor: 11.205

6.  Rat insulin genes: construction of plasmids containing the coding sequences.

Authors:  A Ullrich; J Shine; J Chirgwin; R Pictet; E Tischer; W J Rutter; H M Goodman
Journal:  Science       Date:  1977-06-17       Impact factor: 47.728

7.  Altered gene products are associated with activation of cellular rasK genes in human lung and colon carcinomas.

Authors:  C J Der; G M Cooper
Journal:  Cell       Date:  1983-01       Impact factor: 41.582

8.  Human EJ bladder carcinoma oncogene is homologue of Harvey sarcoma virus ras gene.

Authors:  L F Parada; C J Tabin; C Shih; R A Weinberg
Journal:  Nature       Date:  1982-06-10       Impact factor: 49.962

9.  Dissociation of c-fos from ODC expression and neuronal differentiation in a PC12 subline stably transfected with an inducible N-ras oncogene.

Authors:  I Guerrero; A Pellicer; D E Burstein
Journal:  Biochem Biophys Res Commun       Date:  1988-02-15       Impact factor: 3.575

10.  Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease.

Authors:  J M Chirgwin; A E Przybyla; R J MacDonald; W J Rutter
Journal:  Biochemistry       Date:  1979-11-27       Impact factor: 3.162

View more
  8 in total

1.  Depletion of c-myc with specific antisense sequences reverses the transformed phenotype in ras oncogene-transformed NIH 3T3 cells.

Authors:  M D Sklar; E Thompson; M J Welsh; M Liebert; J Harney; H B Grossman; M Smith; E V Prochownik
Journal:  Mol Cell Biol       Date:  1991-07       Impact factor: 4.272

2.  Antisense-fos RNA causes partial reversion of the transformed phenotypes induced by the c-Ha-ras oncogene.

Authors:  B J Ledwith; S Manam; A R Kraynak; W W Nichols; M O Bradley
Journal:  Mol Cell Biol       Date:  1990-04       Impact factor: 4.272

3.  Oncogene N-ras mediates selective inhibition of c-fos induction by nerve growth factor and basic fibroblast growth factor in a PC12 cell line.

Authors:  T M Thomson; S H Green; R J Trotta; D E Burstein; A Pellicer
Journal:  Mol Cell Biol       Date:  1990-04       Impact factor: 4.272

4.  E1A + cHa-ras transformed rat embryo fibroblast cells are characterized by high and constitutive DNA binding activities of AP-1 dimers with significantly altered composition.

Authors:  T V Pospelova; A V Medvedev; A N Kukushkin; S B Svetlikova; A J van der Eb; J C Dorsman; V A Pospelov
Journal:  Gene Expr       Date:  1999

5.  Repression of platelet-derived growth factor beta-receptor expression by mitogenic growth factors and transforming oncogenes in murine 3T3 fibroblasts.

Authors:  C Vaziri; D V Faller
Journal:  Mol Cell Biol       Date:  1995-03       Impact factor: 4.272

6.  Involvement of a phosphotyrosine protein phosphatase in the suppression of platelet-derived growth factor receptor autophosphorylation in ras-transformed cells.

Authors:  L Tomáska; R J Resnick
Journal:  Biochem J       Date:  1993-07-01       Impact factor: 3.857

7.  Novel revertants of H-ras oncogene-transformed R6-PKC3 cells.

Authors:  R S Krauss; S N Guadagno; I B Weinstein
Journal:  Mol Cell Biol       Date:  1992-07       Impact factor: 4.272

8.  High-resolution analyses of two different classes of tumor cells in situ tagged with alternative histochemical marker genes.

Authors:  W C Lin; T P Pretlow; T G Pretlow; L A Culp
Journal:  Am J Pathol       Date:  1992-12       Impact factor: 4.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.